Antineoplastic Agents and Cancers

Home

Get App

Create

L-asparaginase
- lymphomas
- ALL
Imatinib mesylate
- CML
- GIST
Dasatinib
- CML
- ALL
Lapatinib

breast cancer
Gefitinib

NSCLC
Erlotinib

NSCLC
Alitretinoin

AIDS-related Kaposi's sarcoma
Bexarotene

cutaneous T-cell lymphoma
Arsenic Trioxide

APL
Thalidomide

Multiple myeloma
Lenalidomide

multiple myeloma
Bortezomib

multiple myeloma
Porfimer
- obstructed esophageal cancer
- NSCLC
Temsirolimus

advanced renal cell carcinoma
Vorinostat

CTCL
Combretastatin

Adrenocortical carcinoma
Zoledronic acid
- multiple myeloma
- bony metastases
prednisone

transplant
Mifepristone

adrenal carcinoma
Goserelin acetate
- prostate carcinoma
- pre-menopausal breast cancer
Leuprolide acetate

prostate cancer
Octreotide

chemotherapy-induced diarrhea
Diethylstilbestrol

postmenopausal breast cancer
Estramustine

prostate cancer
Tamoxifen

Tumors expressing estrogen receptors
Fulvestrant

breast cancer
Megestrol acetate
- breat cancer
- endometrium cancer
flutamide

prostate cancer
Letrozole

estrogen receptor unknown
Exemastane

postmenopausal breast cancer
Aldesleukin
- metastatic melanoma
- metastatic renal cell carcinoma
Denileukin diftitox

CTCL
Recombinant Interferon alfa-2a
- Hairy cell leukemia
- AIDS-related Kaposi's sarcoma
- CML
Interferon alpha-2b
- Hairy cell leukemia
- AIDS-related Kaposi's sarcoma
- Malignant melanoma
Rituximab

non-Hodgkin's lymphoma
Trastuzumab

breast cancer
Bevacizumab

metastatic colon and rectal cancer
Panitumumab

colon cancer
Cetuximab
- head and neck cancer
- colorectal cancer
Edrocolomab
- colorectal cancer
- breast cancer
Gemtuzumab ozogamicin

AML
Ibritumomab

NHL
Tositumomab

NHL
anti-PSMA mAb

prostate cancer

Author

pdnguyen

83641

Card Set

Antineoplastic Agents and Cancers

Description

Antineoplastic Agents and Cancers

Updated

5/4/2011, 2:24:07 AM

Show Answers